<?xml version='1.0' encoding='utf-8'?>
<document id="28410920"><sentence text="Potential drug interaction with opioid agonist in the setting of chronic low-dose opioid antagonist use."><entity charOffset="32-38" id="DDI-PubMed.28410920.s1.e0" text="opioid" /><entity charOffset="82-88" id="DDI-PubMed.28410920.s1.e1" text="opioid" /><pair ddi="false" e1="DDI-PubMed.28410920.s1.e0" e2="DDI-PubMed.28410920.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28410920.s1.e0" e2="DDI-PubMed.28410920.s1.e1" /></sentence><sentence text="Low dose naltrexone (LDN) has been evaluated in several small studies for the treatment of inflammatory conditions"><entity charOffset="9-19" id="DDI-PubMed.28410920.s2.e0" text="naltrexone" /><entity charOffset="21-24" id="DDI-PubMed.28410920.s2.e1" text="LDN" /><pair ddi="false" e1="DDI-PubMed.28410920.s2.e0" e2="DDI-PubMed.28410920.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28410920.s2.e0" e2="DDI-PubMed.28410920.s2.e1" /></sentence><sentence text=" It is thought to work through modulation of inflammatory mediators and upregulation of endogenous opioid receptors"><entity charOffset="99-105" id="DDI-PubMed.28410920.s3.e0" text="opioid" /></sentence><sentence text=" This may hypersensitize patients to exogenous opioids" /><sentence text=" Drug-drug interaction screening tools built into electronic health records and other services identify the interaction as risk of opioid withdrawal rather than hypersensitivity" /><sentence text=" We present a case of a drug-drug interaction in a patient who was receiving LDN treatment of multiple sclerosis"><entity charOffset="77-82" id="DDI-PubMed.28410920.s6.e0" text="LDN" /></sentence><sentence text=" The patient received a single dose of oxycodone 5mg that resulted in obtundation unresponsive to painful stimuli necessitating the administration of naloxone boluses and infusion along with admission to the intensive care unit for 1 night"><entity charOffset="39-48" id="DDI-PubMed.28410920.s7.e0" text="oxycodone" /><entity charOffset="150-158" id="DDI-PubMed.28410920.s7.e1" text="naloxone" /><pair ddi="false" e1="DDI-PubMed.28410920.s7.e0" e2="DDI-PubMed.28410920.s7.e0" /><pair ddi="false" e1="DDI-PubMed.28410920.s7.e0" e2="DDI-PubMed.28410920.s7.e1" /></sentence><sentence text=" The patient responded well to naloxone therapy"><entity charOffset="31-39" id="DDI-PubMed.28410920.s8.e0" text="naloxone" /></sentence><sentence text=" He was discharged in satisfactory condition" /><sentence text="" /></document>